UniPharma Co., Ltd. (6621.TWO)
TWD 13.85
(-0.72%)
TWD 13.85
(-0.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 103.22 Million | 128.1 Million | 105.38 Million | 138.63 Million | 154.27 Million |
| Cost of Revenue | 52.2 Million | 53.48 Million | 46.06 Million | 69.31 Million | 80.52 Million |
| Gross Profit | 51.01 Million | 74.61 Million | 59.32 Million | 69.31 Million | 73.75 Million |
| Operating Expenses | 78.32 Million | 95.49 Million | 99.54 Million | 89.93 Million | 100.38 Million |
| Selling, General and Administrative Expenses | 60.48 Million | 69.17 Million | 66.49 Million | 65.07 Million | 66.72 Million |
| Research and Development Expenses | 17.83 Million | 26.31 Million | 33.04 Million | 24.85 Million | 34.83 Million |
| Other Expenses | - | 12.63 Million | -35.32 Million | -36.12 Million | - |
| Cost and Expenses | 130.52 Million | 148.98 Million | 145.6 Million | 159.24 Million | 180.91 Million |
| Operating Income | -27.3 Million | -6.98 Million | -74.3 Million | -55.21 Million | -27.8 Million |
| Interest Expense | 14 Thousand | 39 Thousand | 99 Thousand | 141 Thousand | 163 Thousand |
| Income Tax Expense | - | -581 Thousand | - | - | - |
| Earnings before Tax | -21.81 Million | -7.02 Million | -74.4 Million | -55.35 Million | -25.04 Million |
| Net Income | -21.81 Million | -6.44 Million | -74.4 Million | -55.35 Million | -25.04 Million |
| Earnings Per Share Basic | -0.61 | -0.18 | -2.11 | -1.57 | -0.71 |
| Earnings Per Share Diluted | -0.61 | -0.18 | -2.11 | -1.57 | -0.71 |
| Weighted Average Shares Outstanding | 35.5 Million | 35.48 Million | 35.2 Million | 35.2 Million | 35.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.5 Million | 35.48 Million | 35.2 Million | 35.2 Million | 35.21 Million |
| Gross Margin | 0.49 | 0.58 | 0.56 | 0.50 | 0.48 |
| EBIT Margin | -0.16 | -0.01 | -0.60 | -0.32 | -0.14 |
| Profit Margin | -0.21 | -0.05 | -0.71 | -0.40 | -0.16 |
| EBITDA | -16.25 Million | -1.6 Million | -63.52 Million | -44.03 Million | -13.72 Million |
| Earnings Before Tax Margin | -0.26 | -0.05 | -0.71 | -0.40 | -0.18 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.49 Million | 23.49 Million | 103.22 Million | 26.28 Million | 26.28 Million | 25.32 Million |
| Cost of Revenue | 11.22 Million | 11.22 Million | 52.2 Million | 15.11 Million | 15.11 Million | 10.99 Million |
| Gross Profit | 12.26 Million | 12.26 Million | 51.01 Million | 11.17 Million | 11.17 Million | 14.33 Million |
| Operating Expenses | 19.26 Million | 17.58 Million | 78.32 Million | 20.02 Million | 20.02 Million | 17.36 Million |
| Selling, General and Administrative Expenses | 15.28 Million | 15.28 Million | - | 15.34 Million | 15.34 Million | 14.9 Million |
| Research and Development Expenses | 3.98 Million | 3.98 Million | - | 4.81 Million | 4.81 Million | 4.09 Million |
| Other Expenses | - | - | 3.54 Million | - | - | - |
| Cost and Expenses | 30.49 Million | 28.81 Million | 130.52 Million | 35.13 Million | 35.13 Million | 28.36 Million |
| Operating Income | -7 Million | -7 Million | -21.79 Million | -8.98 Million | -8.98 Million | -4.66 Million |
| Interest Expense | - | - | 14 Thousand | - | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -4.89 Million | -4.89 Million | -21.81 Million | -8.32 Million | -8.32 Million | -2.58 Million |
| Net Income | -4.89 Million | -4.89 Million | -21.81 Million | -8.32 Million | -8.32 Million | -2.58 Million |
| Earnings Per Share Basic | -0.14 | -0.14 | - | -0.23 | -0.23 | -0.08 |
| Earnings Per Share Diluted | -0.14 | -0.14 | - | -0.23 | -0.23 | -0.07 |
| Weighted Average Shares Outstanding | 34.97 Million | 34.97 Million | 35.5 Million | 35.5 Million | 35.5 Million | 34.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 35.5 Million | 34.97 Million | 35.5 Million | 35.5 Million | 35.5 Million | 35.5 Million |
| Gross Margin | 0.52 | 0.52 | 0.49 | 0.43 | 0.43 | 0.57 |
| EBIT Margin | -0.26 | -0.23 | - | -0.31 | -0.31 | -0.17 |
| Profit Margin | -0.21 | -0.21 | -0.21 | -0.32 | -0.32 | -0.10 |
| EBITDA | -6.17 Million | -5.29 Million | - | -8.27 Million | -8.27 Million | -4.21 Million |
| Earnings Before Tax Margin | -0.30 | -0.30 | -0.21 | -0.34 | -0.34 | -0.18 |
UJJIVANSFB
BMGB4
UPMMY
3434
0720
THMO